A real-world data of Pfizer's SARS-CoV-2 vaccines in elderly advanced chronic liver disease patients
Latest Information Update: 13 Aug 2021
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 13 Aug 2021 New trial record
- 26 Jun 2021 Results presented at The International Liver Congress 2021